These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21649470)

  • 1. Differentiated thyroid cancer in two patients with resistance to thyroid hormone.
    Paragliola RM; Lovicu RM; Locantore P; Senes P; Concolino P; Capoluongo E; Pontecorvi A; Corsello SM
    Thyroid; 2011 Jul; 21(7):793-7. PubMed ID: 21649470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
    Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status.
    Karakose M; Caliskan M; Arslan MS; Cakal E; Yesilyurt A; Delibasi T
    Arch Endocrinol Metab; 2015 Aug; 59(4):364-6. PubMed ID: 26331327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid carcinoma in a girl with resistance to thyroid hormone management with triiodothyroacetic acid.
    Ramos-Prol A; Antonia Pérez-Lázaro M; Isabel del Olmo-García M; León-de Zayas B; Moreno-Macián F; Navas-de Solis S; Merino-Torres JF
    J Pediatr Endocrinol Metab; 2013; 26(1-2):133-6. PubMed ID: 23457315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thyroid hormone resistance: variable clinical manifestations in five patients].
    Reinhardt W; Jockenhövel F; Deuble J; Chatterjee VK; Reinwein D; Mann K
    Nuklearmedizin; 1997 Oct; 36(7):250-5. PubMed ID: 9441285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.
    Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK
    Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of resistance to thyroid hormone diagnosed after total thyroidectomy for thyroid cancer.
    Aoyama M; Yamasaki S; Tsuyuguchi M
    J Med Invest; 2015; 62(3-4):268-71. PubMed ID: 26399363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial target organ resistance to thyroid hormone.
    Bode HH; Danon M; Weintraub BD; Maloof F; Crawford JD
    J Clin Invest; 1973 Apr; 52(4):776-82. PubMed ID: 4632689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene.
    Taniyama M; Ishikawa N; Momotani N; Ito K; Ban Y
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):121-4. PubMed ID: 11167935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to thyroid hormone in a patient with coexisting Graves' disease.
    Sivakumar T; Chaidarun S
    Thyroid; 2010 Feb; 20(2):213-6. PubMed ID: 20151830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
    Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thyroxine replacement therapy in patients with thyroid cancer and thyroid hormone resistance syndrome].
    Corsello A
    Recenti Prog Med; 2022 Jun; 113(6):7e-10e. PubMed ID: 35758124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
    Lee JI; Chung YJ; Park SJ; Ryu HS; Cho BY
    Thyroid; 2012 Oct; 22(10):1084-7. PubMed ID: 22873179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
    Lawal IO; Nyakale NE; Harry LM; Lengana T; Mokgoro NP; Vorster M; Sathekge MM
    Nucl Med Commun; 2017 Mar; 38(3):222-227. PubMed ID: 28002173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of resistance to thyroid hormone with thyroid cancer.
    Kim HK; Kim D; Yoo EH; Lee JI; Jang HW; Tan AH; Hur KY; Kim JH; Kim KW; Chung JH; Kim SW
    J Korean Med Sci; 2010 Sep; 25(9):1368-71. PubMed ID: 20808683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Kudo T; Nishihara E; Kihara M; Ito Y; Miya A; Fukata S; Nishikawa M; Nakamura H
    Endocr J; 2019 Nov; 66(11):953-960. PubMed ID: 31270299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
    Ito M; Miyauchi A; Morita S; Kudo T; Nishihara E; Kihara M; Takamura Y; Ito Y; Kobayashi K; Miya A; Kubota S; Amino N
    Eur J Endocrinol; 2012 Sep; 167(3):373-8. PubMed ID: 22711760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.